Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family

Current Opinion in Genetics and Development

Volumn 7, Issue 2, 1997, Pages 170-175

  Hoekstra, Merl F ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BINDING PROTEIN; GROWTH FACTOR; MESSENGER RNA; PROTEIN KINASE; PROTEIN SUBUNIT; RAPAMYCIN;

AMINO ACID SEQUENCE; ARTICLE; ATAXIA TELANGIECTASIA; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; DNA DAMAGE; DROSOPHILA; HUMAN; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE;

EID: 0030977349     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80125-6     Document Type: Article

References (48)

1. Carr AM, Hoekstra MF: The cellular response to DNA damage. Trends Cell Biol 1995, 5:35-40.
2. Keith CT, Schreiber SL: PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 1995, 270:50-51.
3. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672. A broad overview of checkpoints in yeasts and mammalian cells.
4. Allen JB, Zhou Z, Siede W, Friedberg EC, Elledge SJ: The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes Dev 1994, 8:2401-2415.
5. Sanchez Y, Desany BA, Jones WJ, Liu W, Wang B, Elledge SJ: Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 1996, 271:357-360. Mec1p and Tel1p proteins have overlapping function. The authors specifically measure the phosphorylation status of Rad53p protein, which is shown to be phosphorylated in a Mec1p-dependent manner.
6. Bentley NJ, Holtzman DA, Flaggs G, Keegan KS, DeMaggio A, Ford JC, Hoekstra M, Carr AM: The S. pombe rad3 checkpoint gene. EMBO J 1996, 15:6641-6651. A report of the cloning of S. pombe Rad3 gene and a human homolog ATR. Demonstrates that ATR can complement some phenotypes associated wish mutations of MEC1 and identifies a protein kinase activity associated with Rad3 protein that is significantly reduced by point mutations in the kinase domain of Rad3.
7. Cimprich KA, Shin TB, Keith CT, Schreiber SL: cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc Natl Acad Sci USA 1996, 93:2850-2885.
8. Walworth N, Bernards R: rad-dependent responses of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 1996, 271:353-356. Chk1 protein is phosphorylated after DNA damage in a manner dependent on Rad3 and other checkpoint proteins. This study highlights the notion that checkpoint reponses can be mediatad by a protein kinase signalling relay.
9. 1-arresting rapamycin-receptor complex. Nature 1994, 369:756-758.
10. Chiu MI, Katz H, Berlin V: RAPT, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc Natl Acact Sci USA 1994, 91:12574-12578.
11. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH: RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994, 78:35-43
12. Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT: Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 1995, 270:815-822.
13. Heitman J, Movva NR, Hall MN: Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
14. 1 progression. Cell 1983, 73:585-596.
15. Brunn GJ, Williams J, Saber C, Wiederrecht G, Lawrence JC Jr, Abraham RT: Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phospoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 1996, 15:5256-5267. Signalling functions of FRAP are directly affected by defined chemical entities that illustrate PHAS-1 as a downstream substrate for the protein kinase.
16. Brown EJ, Schreiber SL: A signaling pathway to translational control. Cell 1996, 86:517-520. A comprehensive mini-review that outlines the sensitivity of mRNA translation to rapamycin and implicates PHAS-1 in FRAP-regulatect responses; recommended as a source for background references in translation regulation.
17. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL: Control of p70 56 kinase activity of FRAP in vivo. Nature 1995, 377:442-446. An important study that links FRAP to S6 kinase signalling. This paper reveals intrinsic protein kinase activity for FRAP and identifies a possible mechanism for rapamycin regulation of cellular signalling.
18. kiP1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994, 372:570-573.
19. Beretta L, Gingras A-C, Soitkin YV, Hall MN, Sonenburg N: Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 1996, 15:658-664.
20. Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Konry Y, Lin TA, Lawrence JC Jr: cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-1 in aortic smooth muscle cells. Proc Natl Acad Sci USA 1995, 92:7222-7226.
21. Lin T-A, Kong Y, Haystead TAJ, Pause A, Belsham G, Sonenburg N, Lawrence JC Jr: PHAS-1 as a link between mitogen-activated protein kinase and translation initiation. Science 1994, 268:653-556.
22. Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW: Human DNA-activated protein kinase phosphorylates serine 15 and 37 in the amino-terminat transactivation domain of human p53. Mol Cell Biol 1992, 12:5041-5049.
23. Krippschild U, Milne D, Campbell L, Meek D: p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. Oncogene 1996, 13:1387-1393.
24. Biedermann KA, Sun J, Giaccia AJ, Tosto TM, Brown JM: scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci USA 1991, 88:1394-1397.
25. cs complemented a defective cell line.
26. cs, a large protein kinase showing homology to Pl3-kinase and ATM. Despite the Pl3-kinase homology and sensitivity of protein kinase activity to the Pl3-kinase inhibitor wortmannin, DNA-PK lacks lipid kinase function.
27. Jeggo AP, Taccioli GE, Jackson SP: Menage à trois: double strand break repair, V(D)J recombination and DNA-PK. Bioessays 1995, 17:949-957.
28. Feldmann H, Winnacker EL: A putative homologue of the human autoantigen Ku from Saccharomyces cerevisiae. J Biol Chem 1993, 268:12365-12900.
29. Barnes G, Rio D: DNA double-strand-break sensitivity, DNA replication, and cell cycle arrest phenotypes of Ku-deficient Saccharomyces cerevisrae. Proc Natl Acad Sci USA 1997, 94:867-872.
30. Boulton SJ, Jackson SP: Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double-strand break rejoining and in telomeric maintenance. Nucleic Acids Res 1996, 23:4639-4648.
31. Nussenzweig A, Cher C, Da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, Li GC: Requirement for Ku80 in growth and immunoglobulin U(D)J recombination. Nature 1996, 382:551-555.
32. Guidos CJ, Williams CJ, Grandal I, Knowles G, Manley TF, Huang L-C, Danska JS: V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors, Genes Dev 1996, 10:2036-2054. A report of the construction of scid p53 double mutants and the characterization of lymphocyte cell cycle responses. Demonstrates that scid and p53 mutations together accelerate tumorigenesis and reveals tha p53 is unlikely to be in a direct pathway downstream of DNA-PK.
33. Nacht M, Strassor A, Chan YR, Harris AW, Schlissel M, Bronson RT, Jacks T: Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev 1996, 10:2055-2066. See annotation [32*].
34. Fried LM, Koumeris C, Peterson SR, Green SL, Van Zijl P, Allalunis-Turner J, Chen DJ, Fishel R, Giaccia AJ, Brown JM, Kirchgessner CU: The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. Proc Natl Acad Sci USA 1996, 93:13825-13830.
35. Huang L-C, Clarkin KC, Wahl GM: p53-dependenl cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. Cancer Res 1996, 56:2940-2944.
36. Hawley RS, Friend SH: Strange bedfellows in even stranger • places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev 1996, 10:2383-2338. An interesting and synthetic mini-review that develops broad-reaching concepts with regard to PlK kinases in development and cancer. Recommended reading for its lessons in critical thinking.
37. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S et al.: A single ataxia telangiectasia gene with a product similar to Pl3-kinase. Science 1995, 268:1749-1753. Cloning of a partial cDNA encoding the ATM gene mutated in ataxia telangiectasia patients. ATM is related to Pl3-kinase and cell cycle checkpoint genes.
38. Keegan KS, Holtzman DA, Plug AW, Christenson ER, Brainerd EE, Flaggs G, Bentley NJ, Taylor EM, Meyn MS, Moss SB et al.: The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev 1996, 10:2423-2437. The first report of protein kinase activity for ATM and ATR. Antibodies to Atm and Atr protein show related staining patterns on synapsing chromosomes indicative of a role in monitoring recombination and chromosome synapsis.
39. Chen G, Lee EY-H: The product of the ATM gene is a 370 kDa nuclear phosphoprotein. J Biol Chem 1996, 271:33693-33697.
40. Jung M, Kondratyev A, Lee SA, Dimtchev A, Dritschilo A: ATM gene product phosphorylates IkB-α. Cancer Res 1997, 57:24-27.
41. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D: Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphomas. Genes Dev 1996, 10:2411-2422. In this study, mice are deleted for ATM. Studies of the meiotic phenotype indicate a role for ATM in normal cellular meiosis.
42. -l- mouse cell line responses to radiation, This paper extends studies in human ataxia telangiectasia cell lines and suggests a role for ATM in p53 responses to γ-irradiation-induced cell cycle arrest and apoptosis.
43. Barlow C, Hirotsume S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crowley JN, Ried T, Tagle D, Wynshaw-Boris A: ATM-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171, See annotation [41**].
44. Kastan MB, Zriou O, El-Diery WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 1992, 71:587-597.
45. Seaton BL, Yucel J, Sunnerhagen P, Subramani S: Isolation and characterization of the Schizoseccheromyces pombe rad3 gene which is involved in the DNA damage and DNA synthesis checkpoints. Gene 1992, 119:83-89.
46. Kato R, Ogawa H: An essential gene, ESR1, is required for mitotic cell growth, DNA repair and meiotic recombination in Saccharotnyces cerevisiae. Nucleic Acids Res 1994, 22:3104-3112.
47. Hari KL, Santene A, Sekelsky JJ, Mikin KS, Boyd JB, Hawley RS: The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 1995, 82:815-821.
48. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997, 88:265-275. BRCA1 interacts with asynapsed regions of meiosis I chromosomes and binds Rad51. This is the clearest demonstration of nuclear properties for BRCA1 and suggests a role for this breast cancer susceptibility gene in either the control of DNA replication, genetic recombination, or genome integrity.